D-0611-2026 Class II Ongoing
FDA drug recall D-0611-2026 was initiated by Ajanta Pharma USA Inc on May 28, 2026 and is designated Class II. Reason for recall: CGMP Deviations The recall status is ongoing. Affected quantity: 3648 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 1, 2026
- Initiation Date
- May 28, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3648 bottles
Product description
Fenofibrate Capsules, USP 200 mg, Rx only, 100 Capsules, Manufactured by: Ajanta Pharma Limited, India, Marketed by: Ajanta Pharma USA Inc. Bridgewater, NJ 08807, NDC 27241-120-04.
Reason for recall
CGMP Deviations
Distribution pattern
U.S. Nationwide
Code information
Lot # PA02216; Exp. 12/2029
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0611-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026